CYCCP - Cyclacel Pharmaceuticals Inc. (CYCC) CEO Spiro Rombotis on Q4 2020 Results - Earnings Call Transcript
Cyclacel Pharmaceuticals, Inc. (CYCC) Q4 2020 Results Conference Call February 25, 2021 04:30 PM ET Company Participants Jason Assad - Investor Relations Spiro Rombotis - President and Chief Executive Officer Paul McBarron - Executive Vice President, Finance and Chief Operating Officer Dr. Mark Kirschbaum - Senior Vice President and Chief Medical Officer Conference Call Participants Jonathan Aschoff - ROTH Capital Partners Kumar Raja - Brookline Capital Markets Wangzhi Li - Ladenburg Presentation Operator Good afternoon, and welcome to the Cyclacel Pharmaceuticals Fourth Quarter and Full Year 2020 Results Conference Call and Webcast. At this time, all participants are in a listen-only mode. After today's call, members of the financial community will have an opportunity to ask questions. [Operator Instructions] The Company will also be accepting a limited number of questions submitted via e-mail to the address ir@cyclacel.com. [Operator Instructions] Please note, today's call is being recorded. I would now like
For further details see:
Cyclacel Pharmaceuticals, Inc. (CYCC) CEO Spiro Rombotis on Q4 2020 Results - Earnings Call Transcript